Giving in North America
Gilead Sciences funds nonprofit-led projects in North America that advance healthcare access, education, and equity in HIV, liver disease, oncology, and inflammatory/respiratory diseases.
Funder: Gilead Sciences
Due Dates: Rolling (Applications accepted year-round)
Funding Amounts: No set maximum; request the amount needed for your project. Funding typically supports projects up to one year in duration.
Summary: Supports North American nonprofits advancing healthcare access, education, and equity in HIV, liver disease, oncology, and inflammatory/respiratory diseases.
Key Information: Only nonprofits (not individuals or for-profits) are eligible; funding is not retroactive and must be requested at least six weeks before project start.
Description
Gilead Sciences' North America grant program funds nonprofit organizations and healthcare partners working to improve healthcare access, education, and equity in the United States and Canada. The program emphasizes projects in HIV (care, prevention, and cure), liver diseases (including hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and inflammatory/respiratory diseases. Priority is given to innovative, community-engaged initiatives that address health disparities, reduce stigma, and reach underserved populations. Funding can support awareness campaigns, capacity building, screening-to-cure pathways, education for both patients and providers, and efforts to overcome barriers to care.
